DENSO Manufacturing Michigan, Inc. and CHD Meridian Healthcare Open On-Site Pharmacy.

BATTLE CREEK, Mich. & CHADDS FORD, Pa. -- DENSO Manufacturing Michigan, Inc., an industry leader in the design and production of advanced automotive heating and cooling components, and CHD Meridian Healthcare, an I-trax, Inc. (Amex: DMX) company and leader in integrated health and productivity management, announced today the opening of an on-site pharmacy to serve DENSO's more than 2,500 associates and their dependents at its Battle Creek, Michigan location.

An open house will be held at 3:00 p.m. on September 6 and the DENSO Family Pharmacy will be open for business on Wednesday, September 7. Located on the DENSO Manufacturing campus, the pharmacy will be operated, managed and staffed by CHD Meridian Healthcare. It will be staffed with a full-time pharmacist as well as a certified pharmacy technician and will offer over-the-counter pharmacy services, counseling, patient-to-doctor compliance programs, quality assurance, as well as numerous other benefits for DENSO associates.

"We are extremely focused on being the employer of choice in our markets and our new, on-site pharmacy fits in well with our company philosophy," said Karen Cooper-Boyer, General Manager of Associate, Corporate, and Community Resources. "The three primary goals of our on-site pharmacy are to lower the company's rising healthcare costs, pass some savings on to our associates and provide our associates with the convenience of handling their pharmaceutical needs during their work day. We view CHD Meridian Healthcare as a valuable partner in this new venture to not only provide high quality pharmacy services for our associates but to also provide us with direction to help alleviate the healthcare expenditure pains that both we as a company and our associates have been facing."

"In addition to its strong focus on the well-being of its associates and their families, DENSO has recognized the need to take control of its healthcare expenses," said Frank A Martin, chairman of I-trax. "On-site pharmacies are a rapidly growing trend as more employers are realizing the tremendous savings they offer and the convenience they provide their employees. Our pharmacists serve as counselors and educators for our clients' employees, helping them better manage their health and be more knowledgeable healthcare consumers. We believe that this is only the beginning of the growth curve for employer-sponsored, on-site healthcare centers, particularly pharmacies, and DENSO is an excellent example of a company assuming the responsibility of their healthcare expenses."

About DENSO CORPORATION

DENSO Corporation, headquartered in Kariya, Aichi prefecture, Japan, is a leading global supplier of advanced technology, systems and components. Its customers include all the world's major carmakers. Worldwide, the company employs 104,000 people in 31 countries and regions, including Japan. Consolidated global sales for the fiscal year ended March 31, 2005 totaled US$26.2 billion. DENSO common stock is traded on the Tokyo, Osaka and Nagoya stock exchanges. For more information, go to www.globaldenso.com. In the Americas, DENSO employs more than 14,000 people at 33 companies

About I-trax

I-trax is a leading provider of integrated health and productivity management solutions formed by the merger of I-trax Health Management Solutions and CHD Meridian Healthcare. Serving nearly 100 clients at over 185 locations nationwide, I-trax offers wellness, disease management and on-site services. I-trax provides a comprehensive solution specifically designed for every individual regardless of location. Our focus is on improving health, satisfaction and productivity for individuals, while lowering the direct and indirect costs of healthcare related benefits. For more information, visit www.i-trax.com.

Safe Harbor Statement: This news release may contain "forward-looking statements" with the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated, including those risks detailed in I-trax's filings with the Securities and Exchange Commission, and should be read in light of these risks.